Quality of Life Associated with Pulmonary Vascular Disease Archives

The Pulmonary Hypertension Global Patient Survey: Understanding the Invisible Burden of Paediatric Pulmonary Hypertension

Sadia Quyam, Sarah Drumm, Shiv Mungala, Katherine Bunclark, Gerald Fischer, Eva Otter, Hakim Ghani, Wendy Gin‐Sing, Luke Howard, Marcin Kurzyna, Pisana Ferrari, Lynsay Macdonald, Joseph Newman, Millicent Stone, Mark Toshner, Joanna Pepke Zaba, Maurice Beghetti, Shahin MoledinaGreat Ormond Street Hospital for Children and University College London. Pulmonary Vascular Research Institute. Royal Statistical Society. University of […]

The Pulmonary Hypertension Global Patient Survey: Understanding the Invisible Burden of Paediatric Pulmonary Hypertension Read More »

The relationship between muscle strength and oxygenation and activities of daily living in adolescents and young adults with pulmonary arterial hypertension

Jan Dik, Ceyhun Topcuoglu, Naciye Vardar-Yagli, Merve Basol Goksuluk, Ebru Aypar, Dursun Alehan, Melda SaglamHacettepe University. Munzur University. Sakarya University. Turkey Cardiology in the YoungCardiol Young 2026; DOI: 10.1017/S1047951125110895 AbstractPulmonary arterial hypertension leads to dyspnoea, fatigue, and oxygen desaturation, limiting activities of daily living and functional capacity. This study aimed to evaluate the impact of pulmonary

The relationship between muscle strength and oxygenation and activities of daily living in adolescents and young adults with pulmonary arterial hypertension Read More »

Pulmonary arterial hypertension increases the risk of female sexual dysfunction: a systematic review and meta-analysis

Xiaoyu. Qiao, Danyan Su, Suyuan Qin, Lifeng Shang, Liu Luo, Yusheng PangFirst Affiliated Hospital of Guangxi Medical University and Pediatric Clinical Medical Research Center of Guangxi.China Journal of Sexual MedicineJ Sex Med 2025; DOI: 10.1093/jsxmed/qdaf294 AbstractBackground: An increasing body of research has investigated the sexual functioning status in women with pulmonary arterial hypertension (PAH); yet, the evidence

Pulmonary arterial hypertension increases the risk of female sexual dysfunction: a systematic review and meta-analysis Read More »

Exploring Health-Related Quality of Life in Children With Pulmonary Hypertension

Jo Wray, Sadia Quyam, Holly Clisby, Vicky Kelly, Shahin MoledinaGreat Ormond Street Hospital for Children NHS Foundation Trust. Barts Heart and Thorax Centre Psychological Services.United Kingdom Pulmonary CirculationPulm Circ 2025; 15: DOI: 10.1002/pul2.70161 AbstractPulmonary hypertension (PH) in children requires complex medical management. Health-related quality of life (HRQoL) remains understudied in this population. During an 8-month period

Exploring Health-Related Quality of Life in Children With Pulmonary Hypertension Read More »

Global, Regional, and National Burden of Pulmonary Arterial Hypertension from 1990 to 2021 and Projections to 2040: A Systematic Analysis of Incidence, Mortality, and Disability-Adjusted Life Years

Lin-Ling Yu, Ding-Sheng Jiang, Xiong Wang, Ze-Min Fang, Wei-Hong Chen, JinZhu Zhao, Xin Yi, Wei LuTongji Hospital, Tongji Medical College and Huazhong University of Science and Technology. Chinese Academy of Medical Sciences. Renmin Hospital of Wuhan University. China Current Medical ScienceCurr Med Sci 2025; DOI: 10.1007/s11596-025-00108-1 AbstractObjective: Pulmonary arterial hypertension (PAH) poses a growing global health challenge,

Global, Regional, and National Burden of Pulmonary Arterial Hypertension from 1990 to 2021 and Projections to 2040: A Systematic Analysis of Incidence, Mortality, and Disability-Adjusted Life Years Read More »

Trends, Burden, and Inequality in Neonatal Pulmonary Arterial Hypertension: Global Estimates From 1990 to 2021

Xinbao Wang, Zhe Tang, Ziwei WangBeijing Friendship Hospital and Capital Medical University.China Pediatric PulmonologyPediatr Pulmonol 2025; 60: DOI: 10.1002/ppul.71277 AbstractBackground: Pulmonary arterial hypertension (PAH) is a rare but life-threatening disorder in neonates, characterized by increased pulmonary vascular resistance and right heart failure. Despite advances in neonatal intensive care, the global burden of neonatal PAH remains poorly defined,

Trends, Burden, and Inequality in Neonatal Pulmonary Arterial Hypertension: Global Estimates From 1990 to 2021 Read More »

Pediatric pulmonary arterial hypertension: global epidemiology and disease burden during the period 1990 to 2021

Ying Chen, Rongguo Zhang, Yongxiao Zheng, Chenghong Li, Xiaobei Wang, Zhongmei Wen, Fajiu LiSixth Hospital of Wuhan and Affiliated Hospital of Jianghan University. Cheeloo College of Medicine and Shandong University. First Hospital of Jilin University.China Frontiers in Cardiovascular MedicineFront Cardiovasc Med 2025; 12: DOI: 10.3389/fcvm.2025.1544545Correction: DOI: 10.3389/fcvm.2025.1703514 AbstractObjectives: Pediatric pulmonary arterial hypertension (PAH) is a severe and potentially

Pediatric pulmonary arterial hypertension: global epidemiology and disease burden during the period 1990 to 2021 Read More »

Global Burden of Pediatric Pulmonary Arterial Hypertension, 1990-2021: A Systematic Analysis from the Global Burden of Disease Study 2021

Taixiang Liu, Xiaoliang Liu, Chenhong Wang, Jinxin Zheng, Liping Shi, Zheng ChenChildren’s Hospital, Zhejiang University School of Medicine. West China Second University Hospital, Sichuan University. Shanghai Jiao Tong University School of Medicine. China Pediatric CardiologyPediatr Cardiol 2025; DOI: 10.1007/s00246-025-04009-x AbstractPediatric pulmonary arterial hypertension (PAH) remains a critical global health threat characterized by disparities in burden driven

Global Burden of Pediatric Pulmonary Arterial Hypertension, 1990-2021: A Systematic Analysis from the Global Burden of Disease Study 2021 Read More »

Neighborhood Child Opportunity Index and Outcomes in Pediatric Pulmonary Hypertension

Jai Krishan Khurana, Stuart Lipsitz, Diana L. Geisser, Katie M. Moynihan, Mary P. MullenBoston Children’s Hospital, Brigham and Women’s Hospital and Harvard Medical School.United States Pediatric CardiologyPediatr Cardiol 2025; DOI: 10.1007/s00246-025-03981-8 AbstractThe role of social determinants of health (SDoH) in pediatric pulmonary hypertension (PH) outcomes are inadequately characterized. We hypothesized outcomes differ according to SDoH with

Neighborhood Child Opportunity Index and Outcomes in Pediatric Pulmonary Hypertension Read More »

Enhancing Drug Development for Paediatric Pulmonary Hypertension-An Integrative Perspective

Steven H. Abman, Sylvia M. Nikkho, Rolf M. F. Berger, Maria Jesus del Cerro, Eric D. Austin, Maurice Beghetti, Dunbar Ivy, Megan Griffiths, Anne Hilgendorff, Steven H. Kawut, Usha S. Krishnan, Mary P. Mullen, Shahin Moledina, Bernard Thébaud, Norman StockbridgeUniversity of Colorado School of Medicine and Children’s Hospital Colorado. Bayer AG. Beatrix Children’s Hospital, University

Enhancing Drug Development for Paediatric Pulmonary Hypertension-An Integrative Perspective Read More »